Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?

Critical Reviews in Oncology/hematology
Rosalba TorrisiArmando Santoro

Abstract

Germline pathogenic mutations in breast cancer (BC) susceptibility genes (gBRCA1/2) are the most frequent inherited alterations in BC and are involved in the homologous recombination pathway, the principal mechanism of DNA double strand break repair. Platinum salts which act as DNA cross-linking agents are therefore more likely to be active in BRCA-deficient tumors. Women with gBRCA-associated tumors, particularly with triple negative BC, receiving neoadjuvant platinum containing regimens achieved higher pCR rates as compared to wild-type BC. However in two large randomized trials the addition of carboplatin significantly increased pCR rate only in wild-type tumors. On the contrary, the randomized TNT trial showed a significant benefit for carboplatin vs docetaxel in terms of response rate and PFS specifically in patients with advanced gBRCA -associated tumors. Biomarkers of sensitivity to DNA damaging agents beyond gBRCA mutations predicting activity of platinum salts have been proposed and should be validated prospectively.

Citations

Aug 10, 2019·Expert Review of Anticancer Therapy·Jennifer WeissJennifer Diamond
Jul 8, 2020·The Breast Journal·Neelam V Desai, Nadine M Tung
Jul 26, 2019·The Breast : Official Journal of the European Society of Mastology·Shani Paluch-Shimon, Ella Evron
Nov 2, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Oliver TruslerAndrew L Laslett
Feb 6, 2021·Cancers·Svetlana MiklikovaMarina Cihova
Mar 26, 2021·Current Oncology Reports·Elisa AgostinettoEvandro de Azambuja
Sep 21, 2020·Seminars in Cell & Developmental Biology·Nour L MozaffariAlessandro A Sartori
Oct 12, 2020·Internal Medicine Journal·Amy BodyMargaret Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.